Because CARMIL1-AA is more selective than EIPA (Fig. 6a, d and Supplementary Fig. 6a, c), these tumor growth assays also provide more rigorous support for the model that macropinocytosis drives solid tumor growth than published studies using EIPA3,4,8. The gene discussed is CARMIL1; the disease is neoplasm.